This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ooe, N. Articles by Kaneko, H. Search for Related Content PubMed PubMed Citation Articles by Ooe, N. Articles by Kaneko, H.

Identification of a Novel Basic Helix-Loop-Helix-PAS Factor, NXF, Reveals a Sim2 Competitive, Positive Regulatory Role in Dendritic-Cytoskeleton Modulator Drebrin Gene Expression

Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., Konohana-ku, Osaka 554-8558, Japan

Received 12 September 2002/ Returned for modification 28 February 2003/ Accepted 2 October 2003

Sim2, a basic helix-loop-helix (bHLH)-PAS transcriptional repressor, is thought to be involved in some symptoms of Down's syndrome. In the course of searching for hypothetical Sim2 relatives, we isolated another bHLH-PAS factor, NXF. NXF was a novel gene and was selectively expressed in neuronal tissues. While no striking homolog of NXF was found in vertebrates, a Caenorhabditis elegans putative transcription factor, C15C8.2, showed similarity in the bHLH-PAS domain. NXF had an activation domain as a transcription activator, and Arnt-type bHLH-PAS subfamily members were identified as the heterodimer partners of NXF. The NXF/Arnt heterodimer was capable of binding and activating a subset of Sim2/Arnt target DNA variants, and Sim2 could compete with the NXF activity on the elements. We showed that Drebrin had several such NXF/Arnt binding elements on the promoter, which could be direct or indirect cross talking points between NXF (activation) and Sim2 (repression) action. Drebrin has been reported to be engaged in dendritic-cytoskeleton modulation at synapses, and such a novel NXF signaling system on neural gene promoter may be a molecular target of the adverse effects of Sim2 in the mental retardation of Down's syndrome.

This article has been cited by other articles:

• Woods, S., Farrall, A., Procko, C., Whitelaw, M. L. (2008). The bHLH/Per-Arnt-Sim transcription factor SIM2 regulates muscle transcript myomesin2 via a novel, non-canonical E-box sequence. Nucleic Acids Res 36: 3716-3727 [Abstract] [Full Text]  
• Jiang, L., Crews, S. T. (2007). Transcriptional Specificity of Drosophila Dysfusion and the Control of Tracheal Fusion Cell Gene Expression. J. Biol. Chem. 282: 28659-28668 [Abstract] [Full Text]  
• Cooper, S. J., Trinklein, N. D., Nguyen, L., Myers, R. M. (2007). Serum response factor binding sites differ in three human cell types. Genome Res. 17: 136-144 [Abstract] [Full Text]  
• Jiang, L., Crews, S. T. (2006). dysfusion Transcriptional Control of Drosophila Tracheal Migration, Adhesion, and Fusion.. Mol. Cell. Biol. 26: 6547-6556 [Abstract] [Full Text]  
• Marion, J.-F., Yang, C., Caqueret, A., Boucher, F., Michaud, J. L. (2005). Sim1 and Sim2 are required for the correct targeting of mammillary body axons. Development 132: 5527-5537 [Abstract] [Full Text]